"Preview" Icon

Haloperidol

Haldol, Haldol Solutab (haloperidol) is a small molecule pharmaceutical. Haloperidol was first approved as Haldol on 1982-01-01. It is used to treat substance withdrawal syndrome, tourette syndrome, and vomiting in the USA. The pharmaceutical is active against D(3) dopamine receptor, D(2) dopamine receptor, D(4) dopamine receptor, and 5-hydroxytryptamine receptor 2A. In addition, it is known to target D(1B) dopamine receptor, D(1A) dopamine receptor, G protein-activated inward rectifier potassium channel 2, 5-hydroxytryptamine receptor 7, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 1D, potassium voltage-gated channel subfamily H member 1, 5-hydroxytryptamine receptor 2B, histamine H1 receptor, and Endolysin.

$4,995

Want to know more?
Schedule a demo or contact us for additional purchasing options.

Trade Name

Haldol, Haldol Solutab

Common Name

haloperidol

ChEMBL ID

CHEMBL54

Indication

substance withdrawal syndrome, tourette syndrome, vomiting

Drug Class

Antipsychotics (haloperidol type)

Image (chem structure or protein)

Haloperidol structure rendering

$4,995

Want to know more?
Schedule a demo or contact us for additional purchasing options.

Every Drug Dataset Includes...

Full Drug Information

Including:

Trade name (FDA, EMA)

Drug common name

Description

Classification

Drug class

Image (chemical or protein structure)

Protein Data Bank ID

Structure (InChI/SMILES or Protein Sequence)

CAS-ID

RxCUI

ChEMBL ID

ChEBI ID

PubChem CID

DrugBank ID

Indications

Including:

Agency approved indications

Phase 1 Indications

Phase 2 Indications

Phase 3 Indications

Phase 4 Indications

MeSH identifiers

Ontology identifiers

Target Information

Including:

Agency Approved Targets

Alternative Targets

Gene name

Gene synonyms

NCBI Gene ID

Protein name

Protein synonyms

Uniprot ID

Orthologs

Clinical Variant Information

Including:

ClinVar ID

Target mutation

Effect

Evaluation date

PharmGKB level

Clinical Trial Information

Including:

NCT ID

Trial Timeline

Results

Phase

Expanded Access

Official Title

Sponsor

Indications / Phase Indications

Study Type

Enrollment

Inclusion Criteria

Exclusion Criteria

Links to Clinical Trials

Reimbursement Codes

Including:

ICD-10

ATC

HCPCS

Safety Information

Including:

Black Box Warnings

Adverse Events

Adverse Reactions

Expedite Criteria

Trend Information

Including:

Top, trending, and new metadata terms in the following categories:

Disease or Syndrome

Pharmacological Substances

Biological Entities

Laboratory Procedures

Commercial Information

Including:

Company (FDA, EMA)

Approval Date (FDA, EMA)

Exclusivity

Patent Expiration

Generics and Biosimilars (FDA, EMA)

Drug Labels

Economic Information

Including:

Company

Annual revenue

Quarterly revenue

Global sales

US sales

Non-US sales

Full dataset compatible with-

SQL logo
SQL for web applications
<strong>R</strong> for statistical modeling
R for statistical modeling
Spotfire and tableau logos
Spotfire & Tableau for visualization
<strong>CSV</strong> export file format
CSV export file format
JSON logo
JSON export file format
XLSX logo
XLSX export file format

Continually updated information available as a yearly subscription for individual drug-of-interest.

$4,995

Schedule a demo to see what you get or contact us for additional or enterprise purchasing options.